Synergy and competition between cancer genome sequencing and epigenome mapping projects

EDITORIAL SUMMARY: Large-scale projects in the fields of cancer genomics and epigenomics have different aims, cultures and outcomes. The author argues that by working together a complete picture of cancer biology could be painted, and he advocates the creation of an International Cancer Epigenome Co...

Descripción completa

Detalles Bibliográficos
Autor principal: Bock, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062064/
https://www.ncbi.nlm.nih.gov/pubmed/25031623
http://dx.doi.org/10.1186/gm557
_version_ 1782321587731562496
author Bock, Christoph
author_facet Bock, Christoph
author_sort Bock, Christoph
collection PubMed
description EDITORIAL SUMMARY: Large-scale projects in the fields of cancer genomics and epigenomics have different aims, cultures and outcomes. The author argues that by working together a complete picture of cancer biology could be painted, and he advocates the creation of an International Cancer Epigenome Consortium.
format Online
Article
Text
id pubmed-4062064
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40620642015-05-30 Synergy and competition between cancer genome sequencing and epigenome mapping projects Bock, Christoph Genome Med Comment EDITORIAL SUMMARY: Large-scale projects in the fields of cancer genomics and epigenomics have different aims, cultures and outcomes. The author argues that by working together a complete picture of cancer biology could be painted, and he advocates the creation of an International Cancer Epigenome Consortium. BioMed Central 2014-05-30 /pmc/articles/PMC4062064/ /pubmed/25031623 http://dx.doi.org/10.1186/gm557 Text en Copyright © 2014 Bock; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 The licensee has exclusive rights to distribute this article, in any medium, for 12 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Comment
Bock, Christoph
Synergy and competition between cancer genome sequencing and epigenome mapping projects
title Synergy and competition between cancer genome sequencing and epigenome mapping projects
title_full Synergy and competition between cancer genome sequencing and epigenome mapping projects
title_fullStr Synergy and competition between cancer genome sequencing and epigenome mapping projects
title_full_unstemmed Synergy and competition between cancer genome sequencing and epigenome mapping projects
title_short Synergy and competition between cancer genome sequencing and epigenome mapping projects
title_sort synergy and competition between cancer genome sequencing and epigenome mapping projects
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062064/
https://www.ncbi.nlm.nih.gov/pubmed/25031623
http://dx.doi.org/10.1186/gm557
work_keys_str_mv AT bockchristoph synergyandcompetitionbetweencancergenomesequencingandepigenomemappingprojects

Ejemplares similares